Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joaquim Cabanas

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Virological Methods|May 23, 2013
Comparison of the NucliSENS EasyQ HIV-1 v2.0 with Abbott m2000rt RealTime HIV-1 assay for plasma RNA quantitation in different HIV-1 subtypesPerpétua Gomes, Ana Patrícia Carvalho, Isabel Diogo, et al.
Journal of the International AIDS Society|November 15, 2014
A retrospective observational study of low-level viraemia and its immunological and virological significance: which outcome to expectJoana Silva, Karen Pereira, Joao Rijo, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 26, 2015
Discordant predictions of residual activity could impact dolutegravir prescription upon raltegravir failureKristof Theys, Ana Abecasis, Pieter Libin, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|July 7, 2009
Effect of human immunodeficiency virus type 1 protease inhibitor therapy and subtype on development of resistance in subtypes B and GAna Carolina Palma, Ana Barroso Abecasis, Jurgen Vercauteren, et al.
AIDS (London, England)|November 14, 2025
Emerging patterns in HIV integrase resistanceMargarida Veloso, Marta Ribeiro, Joaquim Cabanas, et al.
Journal of Virological Methods|May 6, 2006
Comparison of the COBAS TAQMAN HIV-1 HPS with VERSANT HIV-1 RNA 3.0 assay (bDNA) for plasma RNA quantitation in different HIV-1 subtypesPerpétua Gomes, Ana Carolina Palma, Joaquim Cabanas, et al.
Viruses|April 28, 2018
Characterization of <i>NS5A</i> and <i>NS5B</i> Resistance-Associated Substitutions from Genotype 1 Hepatitis C Virus Infected Patients in a Portuguese CohortRuben Brandão, Rute Marcelino, Fátima Gonçalves, et al.
Journal of Virological Methods|February 9, 2025
Hybrid next-generation sequencing protocol for testing HIV-2 drug resistanceFátima Gonçalves, Joaquim Cabanas, Inês Costa, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 21, 2026
HIV-1 Late Diagnosis: Strategies to overcome the misclassification of HIV-1 acutely infected individuals as individuals diagnosed lateMafalda N S Miranda, Victor Pimentel, André Santos, et al.
AIDS (London, England)|June 1, 2016
Transmitted drug resistance in drug-naïve HIV-2 infected patientsFrederico Duarte, Ana Cláudia Miranda, Susana Peres, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Virological Methods|May 23, 2013
Comparison of the NucliSENS EasyQ HIV-1 v2.0 with Abbott m2000rt RealTime HIV-1 assay for plasma RNA quantitation in different HIV-1 subtypesPerpétua Gomes, Ana Patrícia Carvalho, Isabel Diogo, et al.
Journal of the International AIDS Society|November 15, 2014
A retrospective observational study of low-level viraemia and its immunological and virological significance: which outcome to expectJoana Silva, Karen Pereira, Joao Rijo, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 26, 2015
Discordant predictions of residual activity could impact dolutegravir prescription upon raltegravir failureKristof Theys, Ana Abecasis, Pieter Libin, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|July 7, 2009
Effect of human immunodeficiency virus type 1 protease inhibitor therapy and subtype on development of resistance in subtypes B and GAna Carolina Palma, Ana Barroso Abecasis, Jurgen Vercauteren, et al.
AIDS (London, England)|November 14, 2025
Emerging patterns in HIV integrase resistanceMargarida Veloso, Marta Ribeiro, Joaquim Cabanas, et al.
Journal of Virological Methods|May 6, 2006
Comparison of the COBAS TAQMAN HIV-1 HPS with VERSANT HIV-1 RNA 3.0 assay (bDNA) for plasma RNA quantitation in different HIV-1 subtypesPerpétua Gomes, Ana Carolina Palma, Joaquim Cabanas, et al.
Viruses|April 28, 2018
Characterization of <i>NS5A</i> and <i>NS5B</i> Resistance-Associated Substitutions from Genotype 1 Hepatitis C Virus Infected Patients in a Portuguese CohortRuben Brandão, Rute Marcelino, Fátima Gonçalves, et al.
Journal of Virological Methods|February 9, 2025
Hybrid next-generation sequencing protocol for testing HIV-2 drug resistanceFátima Gonçalves, Joaquim Cabanas, Inês Costa, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 21, 2026
HIV-1 Late Diagnosis: Strategies to overcome the misclassification of HIV-1 acutely infected individuals as individuals diagnosed lateMafalda N S Miranda, Victor Pimentel, André Santos, et al.
AIDS (London, England)|June 1, 2016
Transmitted drug resistance in drug-naïve HIV-2 infected patientsFrederico Duarte, Ana Cláudia Miranda, Susana Peres, et al.
Pageof 2